Koenraad Wiedhaup

Episode: 30

50 min

Koenraad Wiedhaup, founder and CEO of Leyden Labs is committed to helping people strive for a fantastic life by bringing scientific developments to those who need them. He has worked with biopharmaceutical and life science companies as a partner at McKinsey & Company. Together with executive leadership, he developed business and commercial strategies, including launching products and M&A. Prior to McKinsey, Koenraad worked in business development of a San Francisco based biotech company. He has an background in Life Sciences at the Delft and Leiden Universities and holds an MBA from Columbia Business School in New York.

Koenraad Wiedhaup, founder and CEO of Leyden Labs is committed to helping people strive for a fantastic life by bringing scientific developments to those who need them. He has worked with biopharmaceutical and life science companies as a partner at McKinsey & Company. Together with executive leadership, he developed business and commercial strategies, including launching products and M&A. Prior to McKinsey, Koenraad worked in business development of a San Francisco based biotech company. He has an background in Life Sciences at the Delft and Leiden Universities and holds an MBA from Columbia Business School in New York.

0:00/1:34

Dimitri de Vreeze

Episode: 58

53 min

Dimitri de Vreeze is CEO van DSM-Firmenich.

Dimitri de Vreeze is CEO van DSM-Firmenich.

Carla Hollak

Episode: 57

47 min

Carla Hollak is hoogleraar Medicijnen en Maatschappij aan het UMC Amsterdam en Chair van RARE-NL

Carla Hollak is hoogleraar Medicijnen en Maatschappij aan het UMC Amsterdam en Chair van RARE-NL

Sander van Asbeck

Episode: 56

46 min

Sander van Asbeck is CEO en co-founder van Ribopro, een bedrijf dat zich richt op mRNA

Sander van Asbeck is CEO en co-founder van Ribopro, een bedrijf dat zich richt op mRNA

Load More Podcast